Piroxicam Tablet

Modelo NO .: TBL0011 Produto: Piroxicam Tablet Dosagem: Oral. Dose usual do adulto: Um 20mg, 1 hora um o dia, ou vida de prateleira: Pacote de três anos: Nós podemos fazer como Ur requisite ou podemos usar nosso próprio PAC Especificação: OEM / GMP Nome do artigo: Piroxicam Propriedades da tabuleta: Sugar-Coated Tablet, Remove O revestimento do açúcar era forma farmacêutica: Comprimidos Armazenamento: Não armazenar acima de 25c. Loja no PAC original Remark: OEM disponível Origem: China

Piroxicam comprimido

Especificações
1 & period; Comprimido Diclofenac & amp; , GMP aprovado
2 & período; Boa qualidade e bom preço & período;
3 & period; Terminado medicina & período;

4 & period; Serviço de OEM

Product:	Piroxicam tablet
Properties	sugar-coated tablet, remove the sugar coating was white or yellowish green.
Indications	symptomatic treatment for the relief of all kinds of arthritis and soft tissue lesions of pain and swelling.
Dosage	Oral. Adult usual dose: one 20mg, 1 time a day, or once l0mg, 2 times a day. After meals.
Adverse reactions	1. Nausea, stomach pain, indigestion and other gastrointestinal sodium reduction and the most common adverse reactions, of which 3.5% required for this withdrawal. When the day is greater than 20mg medication significantly higher incidence of gastric ulcer, some hemorrhage, or perforation. 2. Neutropenia, eosinophilia, blood urea nitrogen increased, dizziness, vertigo, tinnitus, headache, weakness, edema, rash or itching. 3. Liver dysfunction, thrombocytopenia, sweating, skin bruising, peeling, erythema multiforme, toxic epithelial necrosis, bullous erythema multiforme (Stevens-Johnson syndrome), allergic skin to light, blurred vision, eye Department of swelling, high blood pressure, urine, low blood sugar, depression, insomnia and mental stress.
Taboo	right for the allergy, peptic ulcer, chronic stomach disabled patients.
NOTES	1. Cross allergy. Patients with aspirin or other non-steroidal anti-inflammatory drug allergy may be allergic to this product. 2. Administered after a meal or with food or antacids with clothing to reduce gastrointestinal irritation. 3. Danger day more than 20mg, gastrointestinal ulcers increased significantly. 4. Generally 7 to 12 days after treatment began, it is difficult to achieve stable blood concentration, therefore, often have to evaluate the efficacy of the two weeks after treatment. 5. In case of an allergic reaction during the treatment, blood abnormalities, blurred vision, mental symptoms, water retention when left and severe gastrointestinal reactions should be immediately discontinued. 6. The following should be careful: (1) When the clotting mechanism or platelet dysfunction; (2) Asthma; (3) heart failure or high blood pressure; (4) renal insufficiency; (5) the elderly. 7. Long-term drug users should be regularly reviewed liver and kidney function and blood. 8. This product is a symptomatic treatment, must be the cause of treatment at the same time. 9. Can inhibit platelet aggregation, the role of weaker than aspirin, but continued until 2 weeks after stopping. Preoperative and postoperative should be discontinued.
Pregnant and lactating women	1. After three months of pregnancy, pregnant women can inhibit delivery of medication, resulting in dystocia, while there may be gastrointestinal toxicity. In addition, long-term medication late in pregnancy may cause fetal ductus arteriosus early atresia or stenosis, resulting in newborns with persistent pulmonary hypertension and heart failure. Pregnant women, disabled. 2. This product can cause milk secretion, and dosage related, lactating women should not use.
Pediatric Use	disabled.
Geriatric Use	caution.

Grupo de Produto : Comprimidos